Literature DB >> 28532255

Outpatient versus inpatient management for superimposed preeclampsia without severe features: a retrospective, multicenter study.

Corina N Schoen1, Sindy C Moreno1, Gabriele Saccone2, Nora M Graham1, Lauren C Hand1, Giuseppe M Maruotti2, Pasquale Martinelli2, Vincenzo Berghella1, Amanda Roman1.   

Abstract

PURPOSE: To determine if women with preterm superimposed preeclampsia without severe features can be successfully and safely triaged to outpatient management.
MATERIALS AND METHODS: This was a multicenter, retrospective, cohort study of singleton pregnancies with superimposed preeclampsia without severe features diagnosed before 37 weeks managed outpatient versus inpatient at Thomas Jefferson University (Philadelphia, PA) and at University of Naples (Naples, Italy) from January 2008 to July 2015. The attending physician made the decision to manage outpatient or inpatient at his or her discretion. The primary outcome was composite maternal morbidity defined as development of at least one of the following: severe features, HELLP syndrome, placental abruption, eclampsia, postpartum hemorrhage, intensive care unit admission, or maternal death. Logistic regression, presented as adjusted odds ratio (aOR) with the 95% of confidence interval (CI) was performed.
RESULTS: A total of 365 women with superimposed preeclampsia without severe features before 37 weeks were analyzed. 198 (54.2%) were managed outpatient, and 167 (45.8%) were managed inpatient. Women managed as outpatients had a similar rate of maternal morbidity compared to those managed as inpatients (36.4% versus 41.3%, aOR 0.82, 95%CI 0.55-1.17). Fetuses from women in the outpatient group had a significantly lower risk of small for gestational age (17.7% versus 29.3%; aOR 0.53, 95%CI 0.30-0.84), and lower risk of admission to neonatal intensive care unit (40.4% versus 47.9%; aOR 0.72, 95%CI 0.39-0.95) compared to women managed as inpatients.
CONCLUSIONS: Low risk women with superimposed preeclampsia without severe features can be triaged to outpatient management without increased maternal morbidity.

Entities:  

Keywords:  Hypertension; management; outcome; outpatient; preeclampsia

Mesh:

Year:  2017        PMID: 28532255     DOI: 10.1080/14767058.2017.1333101

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

1.  The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Offer Erez; Adi L Tarca; Agustin Conde-Agudelo; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo; Steven J Korzeniewski
Journal:  Am J Obstet Gynecol       Date:  2017-10-13       Impact factor: 8.661

2.  Adiponectin Participates in Preeclampsia by Regulating the Biological Function of Placental Trophoblasts through P38 MAPK-STAT5 Pathway.

Authors:  Gaoxia Dong; Ying Tian; Xinqin Li
Journal:  Iran J Public Health       Date:  2018-12       Impact factor: 1.429

3.  Clinical Utility of Weekly Laboratory Testing in the Outpatient Management of Preeclampsia and Gestational Hypertension.

Authors:  John A Morgan; Lauren E McCalmont; Craig V Towers; Melissa Davis; Miriam Hankins; Niyati Rangnekar; Mary Ellen McNeal; David F Lewis
Journal:  AJP Rep       Date:  2020-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.